Obstructive Sleep Apnea–Hypopnea Syndrome and Nonalcoholic Fatty Liver Disease: Emerging Evidence and Mechanisms

 

 Buy Article Permissions and Reprints

Abstract

Obstructive sleep apnea syndrome (OSAS) and nonalcoholic fatty liver disease (NAFLD) are common conditions, frequently encountered in patients with metabolic disorders. OSAS has been associated with an increased risk of cardiovascular and metabolic complications. It has been recently suggested that the chronic intermittent hypoxia of OSAS may also affect the presence and severity of NAFLD. We will critically review experimental and human evidence connecting OSAS to NAFLD pathogenesis, trying to dissect the effect of intermittent hypoxia from that of obesity and associated comorbidities, and examine molecular mechanisms connecting OSAS to liver and metabolic disease in NAFLD, including hypoxia inducible factor (HIF), nuclear factor-kappa B, unfolded protein response, hypoxic adipose tissue inflammation, and their therapeutic potential for NAFLD and its complications, including cirrhosis and hepatocellular carcinoma. Finally, we will provide suggestions for the management of NAFLD patients with suspected OSAS and recommendations for future research.

• References

• 1 Younossi ZM, Stepanova M, Afendy M , et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9 (6) 524-530 , e1, quiz e60
  CrossrefPubMedGoogle Scholar
• 2 Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43 (8) 617-649
  CrossrefPubMedGoogle Scholar
• 3 Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010; 52 (3) 1156-1161
  CrossrefPubMedGoogle Scholar
• 4 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328 (17) 1230-1235
  Google Scholar
• 5 Lindberg E, Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000; 4 (5) 411-433
  CrossrefPubMedGoogle Scholar
• 6 West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006; 61 (11) 945-950
  CrossrefPubMedGoogle Scholar
• 7 Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25 (9) 735-741
  CrossrefPubMedGoogle Scholar
• 8 Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464) 1046-1053
  CrossrefPubMedGoogle Scholar
• 9 Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011; 140 (2) 534-542
  CrossrefPubMedGoogle Scholar
• 10 Sharma SK, Agrawal S, Damodaran D , et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011; 365 (24) 2277-2286
  CrossrefPubMedGoogle Scholar
• 11 Abe H, Takahashi M, Yaegashi H , et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels 2010; 25 (1) 63-69
  CrossrefPubMedGoogle Scholar
• 12 Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176 (7) 706-712
  CrossrefPubMedGoogle Scholar
• 13 Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ ; International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008; 81 (1) 2-12
  CrossrefPubMedGoogle Scholar
• 14 Iber C, Ancoli-Israel S, Chesson A , et al. The AASM manual for snoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007
  Google Scholar
• 15 Dancey DR, Hanly PJ, Soong C, Lee B, Shepard Jr J, Hoffstein V. Gender differences in sleep apnea: the role of neck circumference. Chest 2003; 123 (5) 1544-1550
  CrossrefPubMedGoogle Scholar
• 16 Strauss RS, Browner WS. Risk for obstructive sleep apnea. Ann Intern Med 2000; 132 (9) 758-759
  PubMedGoogle Scholar
• 17 Rowley JA, Aboussouan LS, Badr MS. The use of clinical prediction formulas in the evaluation of obstructive sleep apnea. Sleep 2000; 23 (7) 929-938
  PubMedGoogle Scholar
• 18 Mulgrew AT, Fox N, Ayas NT, Ryan CF. Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann Intern Med 2007; 146 (3) 157-166
  CrossrefPubMedGoogle Scholar
• 19 Magalang UJ, Dmochowski J, Veeramachaneni S , et al. Prediction of the apnea-hypopnea index from overnight pulse oximetry. Chest 2003; 124 (5) 1694-1701
  CrossrefPubMedGoogle Scholar
• 20 Cheliout-Heraut F, Senny F, Djouadi F, Ouayoun M, Bour F. Obstructive sleep apnoea syndrome: comparison between polysomnography and portable sleep monitoring based on jaw recordings. Neurophysiol Clin 2011; 41 (4) 191-198
  CrossrefPubMedGoogle Scholar
• 21 Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000; 31 (2) 255-260
  CrossrefPubMedGoogle Scholar
• 22 Fandrey J, Gassmann M. Oxygen sensing and the activation of the hypoxia inducible factor 1 (HIF-1)—invited article. Adv Exp Med Biol 2009; 648: 197-206
  PubMedGoogle Scholar
• 23 Broughan TA, Naukam R, Tan C, Van De Wiele CJ, Refai H, Teague TK. Effects of hepatic zonal oxygen levels on hepatocyte stress responses. J Surg Res 2008; 145 (1) 150-160
  CrossrefPubMedGoogle Scholar
• 24 Baze MM, Schlauch K, Hayes JP. Gene expression of the liver in response to chronic hypoxia. Physiol Genomics 2010; 41: 275-288
  CrossrefPubMedGoogle Scholar
• 25 Piguet AC, Stroka D, Zimmermann A, Dufour JF. Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clin Sci (Lond) 2010; 118 (6) 401-410
  CrossrefPubMedGoogle Scholar
• 26 Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol 2011; 111 (3) 881-890
  CrossrefPubMedGoogle Scholar
• 27 Choi JH, Park MJ, Kim KW , et al. Molecular mechanism of hypoxia-mediated hepatic gluconeogenesis by transcriptional regulation. FEBS Lett 2005; 579 (13) 2795-2801
  CrossrefPubMedGoogle Scholar
• 28 Kietzmann T, Cornesse Y, Brechtel K, Modaressi S, Jungermann K. Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. Biochem J 2001; 354 (Pt 3) 531-537
  CrossrefPubMedGoogle Scholar
• 29 Kenneth NS, Rocha S. Regulation of gene expression by hypoxia. Biochem J 2008; 414 (1) 19-29
  CrossrefPubMedGoogle Scholar
• 30 Dimova EY, Kietzmann T. Hypoxia-inducible factors: post-translational crosstalk of signaling pathways. Methods Mol Biol 2010; 647: 215-236
  PubMedGoogle Scholar
• 31 Jaakkola P, Mole DR, Tian YM , et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292 (5516) 468-472
  CrossrefPubMedGoogle Scholar
• 32 Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ. An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 2009; 37 (14) 4587-4602
  CrossrefPubMedGoogle Scholar
• 33 Rankin EB, Rha J, Selak MA , et al. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 2009; 29 (16) 4527-4538
  CrossrefPubMedGoogle Scholar
• 34 Qu A, Taylor M, Xue X , et al. Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology 2011; 54 (2) 472-483
  CrossrefPubMedGoogle Scholar
• 35 Nath B, Levin I, Csak T , et al. Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 2011; 53 (5) 1526-1537
  CrossrefPubMedGoogle Scholar
• 36 Li J, Savransky V, Nanayakkara A, Smith PL, O'Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 2007; 102 (2) 557-563
  PubMedGoogle Scholar
• 37 Drager LF, Li J, Shin MK , et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J 2011;
  PubMedGoogle Scholar
• 38 Kucejova B, Sunny NE, Nguyen AD , et al. Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death. Oncogene 2011; 30 (18) 2147-2160
  CrossrefPubMedGoogle Scholar
• 39 Marín-Hernández A, Gallardo-Pérez JC, Ralph SJ, Rodríguez-Enríquez S, Moreno-Sánchez R. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 2009; 9 (9) 1084-1101
  CrossrefPubMedGoogle Scholar
• 40 Copple BL, Bai S, Moon JO. Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic Kupffer cells. Hepatol Res 2010; 40 (5) 530-539
  CrossrefPubMedGoogle Scholar
• 41 Moon JO, Welch TP, Gonzalez FJ, Copple BL. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009; 296 (3) G582-G592
  CrossrefPubMedGoogle Scholar
• 42 Copple BL, Bai S, Burgoon LD, Moon JO. Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis. Liver Int 2011; 31 (2) 230-244
  CrossrefPubMedGoogle Scholar
• 43 Shi YF, Fong CC, Zhang Q , et al. Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway. FEBS Lett 2007; 581 (2) 203-210
  CrossrefPubMedGoogle Scholar
• 44 Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009; 48 (1) 1-26
  CrossrefPubMedGoogle Scholar
• 45 Imtiyaz HZ, Williams EP, Hickey MM , et al. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 2010; 120 (8) 2699-2714
  CrossrefPubMedGoogle Scholar
• 46 Gambino R, Musso G, Cassader M. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal 2011; 15 (5) 1325-1365
  CrossrefPubMedGoogle Scholar
• 47 Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H. Angiogenesis in chronic liver disease and its complications. Liver Int 2011; 31 (2) 146-162
  CrossrefPubMedGoogle Scholar
• 48 Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010; 51 (5) 1820-1832
  CrossrefPubMedGoogle Scholar
• 49 Bangoura G, Liu ZS, Qian Q, Jiang CQ, Yang GF, Jing S. Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol 2007; 13 (23) 3176-3182
  PubMedGoogle Scholar
• 50 Dai CX, Gao Q, Qiu SJ , et al. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer 2009; 9: 418
  CrossrefPubMedGoogle Scholar
• 51 Daskalow K, Rohwer N, Raskopf E , et al. Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma. J Mol Med (Berl) 2010; 88 (8) 817-827
  CrossrefPubMedGoogle Scholar
• 52 Sun X, Jiang H, Jiang X , et al. Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats. Hum Gene Ther 2009; 20 (4) 314-324
  CrossrefPubMedGoogle Scholar
• 53 Greenberger LM, Horak ID, Filpula D , et al. A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth. Mol Cancer Ther 2008; 7 (11) 3598-3608
  CrossrefPubMedGoogle Scholar
• 54 Liu F, Wang P, Jiang X , et al. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Sci 2008; 99 (10) 2055-2061
  PubMedGoogle Scholar
• 55 Clément S, Juge-Aubry C, Sgroi A , et al. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes. Hepatology 2008; 48 (3) 799-807
  CrossrefPubMedGoogle Scholar
• 56 Alisi A, Panera N, Balsano C, Nobili V. Activation of the endotoxin/toll-like receptor 4 pathway: the way to go from nonalcoholic steatohepatitis up to hepatocellular carcinoma. Hepatology 2011; 53 (3) 1069
  CrossrefPubMedGoogle Scholar
• 57 Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care 2010; 33 (10) 2277-2284
  CrossrefPubMedGoogle Scholar
• 58 Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011; 54 (1) 133-144
  CrossrefPubMedGoogle Scholar
• 59 Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011; 62: 361-380
  CrossrefPubMedGoogle Scholar
• 60 Scharte M, Han X, Uchiyama T, Tawadrous Z, Delude RL, Fink MP. LPS increases hepatic HIF-1alpha protein and expression of the HIF-1-dependent gene aldolase A in rats. J Surg Res 2006; 135 (2) 262-267
  CrossrefPubMedGoogle Scholar
• 61 Rius J, Guma M, Schachtrup C , et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008; 453 (7196) 807-811
  CrossrefPubMedGoogle Scholar
• 62 Mauro C, Leow SC, Anso E , et al. NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol 2011; 13 (10) 1272-1279
  CrossrefPubMedGoogle Scholar
• 63 Nácher M, Farré R, Montserrat JM , et al. Biological consequences of oxygen desaturation and respiratory effort in an acute animal model of obstructive sleep apnea (OSA). Sleep Med 2009; 10 (8) 892-897
  CrossrefPubMedGoogle Scholar
• 64 Jelic S, Lederer DJ, Adams T , et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010; 121 (8) 1014-1021
  CrossrefPubMedGoogle Scholar
• 65 Lam JC, Mak JC, Ip MS. Obesity, obstructive sleep apnea and metabolic syndrome. Respirology 2012; 17 (2) 223-236
  CrossrefPubMedGoogle Scholar
• 66 Beraza N, Malato Y, Vander Borght S , et al. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 2008; 57 (5) 655-663
  CrossrefPubMedGoogle Scholar
• 67 Videla LA, Tapia G, Rodrigo R , et al. Liver NF-kappaB and AP-1 DNA binding in obese patients. Obesity (Silver Spring) 2009; 17 (5) 973-979
  CrossrefPubMedGoogle Scholar
• 68 Luedde T, Schwabe RFNF. NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2011; 8 (2) 108-118
  CrossrefPubMedGoogle Scholar
• 69 He G, Karin MNF. NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res 2011; 21 (1) 159-168
  Google Scholar
• 70 Robinson SM, Mann DA. Role of nuclear factor kappaB in liver health and disease. Clin Sci (Lond) 2010; 118 (12) 691-705
  CrossrefPubMedGoogle Scholar
• 71 Culver C, Sundqvist A, Mudie S, Melvin A, Xirodimas D, Rocha S. Mechanism of hypoxia-induced NF-kappaB. Mol Cell Biol 2010; 30 (20) 4901-4921
  CrossrefPubMedGoogle Scholar
• 72 Melvin A, Mudie S, Rocha S. Further insights into the mechanism of hypoxia-induced NFκB. [corrected]. Cell Cycle 2011; 10 (6) 879-882
  PubMedGoogle Scholar
• 73 Li J, Fan R, Zhao S , et al. Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells. Int J Mol Sci 2011; 12 (4) 2434-2447
  CrossrefPubMedGoogle Scholar
• 74 Snapp E, Endoplasmic reticulum biogenesis proliferation and differentiation. In: Mullins C. , ed. The Biogenesis of Cellular Organelles. New York: Kluwer Academic/Plenum; 2005: 63-95
  CrossrefGoogle Scholar
• 75 Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011; 54 (4) 795-809
  CrossrefPubMedGoogle Scholar
• 76 Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334 (6059) 1081-1086
  CrossrefPubMedGoogle Scholar
• 77 Hetz C, Martinon F, Rodriguez D, Glimcher LH. The unfolded protein response: integrating stress signals through the stress sensor IRE1α. Physiol Rev 2011; 91 (4) 1219-1243
  CrossrefPubMedGoogle Scholar
• 78 Diehl JA, Fuchs SY, Koumenis C. The cell biology of the unfolded protein response. Gastroenterology 2011; 141 (1) 38-41 , 41, e1–e2
  CrossrefPubMedGoogle Scholar
• 79 Rahman SM, Schroeder-Gloeckler JM, Janssen RC , et al. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology 2007; 45 (5) 1108-1117
  CrossrefPubMedGoogle Scholar
• 80 Kammoun HL, Chabanon H, Hainault I , et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 2009; 119 (5) 1201-1215
  CrossrefPubMedGoogle Scholar
• 81 Rinella ME, Siddiqui MS, Gardikiotes K, Gottstein J, Elias M, Green RM. Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis. Hepatology 2011; 54 (5) 1600-1609
  CrossrefPubMedGoogle Scholar
• 82 Glimcher LH, Lee AH. From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis. Ann N Y Acad Sci 2009; 1173 (Suppl 1) E2-E9
  CrossrefPubMedGoogle Scholar
• 83 Ning J, Hong T, Ward A , et al. Constitutive role for IRE1α-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program. Endocrinology 2011; 152 (6) 2247-2255
  CrossrefPubMedGoogle Scholar
• 84 Gentile CL, Frye M, Pagliassotti MJ. Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. Antioxid Redox Signal 2011; 15 (2) 505-521
  CrossrefPubMedGoogle Scholar
• 85 Gregor MF, Yang L, Fabbrini E , et al. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 2009; 58 (3) 693-700
  PubMedGoogle Scholar
• 86 Puri P, Mirshahi F, Cheung O , et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 2008; 134 (2) 568-576
  CrossrefPubMedGoogle Scholar
• 87 Al-Rawashdeh FY, Scriven P, Cameron IC, Vergani PV, Wyld L. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2010; 22 (9) 1099-1105
  CrossrefPubMedGoogle Scholar
• 88 Blais JD, Addison CL, Edge R , et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol 2006; 26 (24) 9517-9532
  CrossrefPubMedGoogle Scholar
• 89 van den Beucken T, Magagnin MG, Jutten B , et al. Translational control is a major contributor to hypoxia induced gene expression. Radiother Oncol 2011; 99 (3) 379-384
  CrossrefPubMedGoogle Scholar
• 90 Zhu Y, Fenik P, Zhan G, Sanfillipo-Cohn B, Naidoo N, Veasey SC. Eif-2a protects brainstem motoneurons in a murine model of sleep apnea. J Neurosci 2008; 28 (9) 2168-2178
  CrossrefPubMedGoogle Scholar
• 91 Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165 (5) 670-676
  CrossrefPubMedGoogle Scholar
• 92 Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165 (5) 677-682
  CrossrefPubMedGoogle Scholar
• 93 Makino S, Handa H, Suzukawa K , et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006; 64 (1) 12-19
  CrossrefPubMedGoogle Scholar
• 94 Polotsky VY, Li J, Punjabi NM , et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552 (Pt 1) 253-264
  CrossrefPubMedGoogle Scholar
• 95 Iiyori N, Alonso LC, Li J , et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007; 175 (8) 851-857
  CrossrefPubMedGoogle Scholar
• 96 Oltmanns KM, Gehring H, Rudolf S , et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169 (11) 1231-1237
  CrossrefPubMedGoogle Scholar
• 97 Schahin SP, Nechanitzky T, Dittel C , et al. Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome. Med Sci Monit 2008; 14 (3) CR117-CR121
  PubMedGoogle Scholar
• 98 Harsch IA, Schahin SP, Radespiel-Tröger M , et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169 (2) 156-162
  PubMedGoogle Scholar
• 99 Lam JC, Lam B, Yao TJ , et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 2010; 35 (1) 138-145
  CrossrefPubMedGoogle Scholar
• 100 Musso G, Gambino R, Durazzo M , et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42 (5) 1175-1183
  CrossrefPubMedGoogle Scholar
• 101 Musso G, Gambino R, Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 2010; 11 (6) 430-445
  PubMedGoogle Scholar
• 102 Xu H, Barnes GT, Yang Q , et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112 (12) 1821-1830
  CrossrefPubMedGoogle Scholar
• 103 Makkonen J, Westerbacka J, Kolak M , et al. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. Int J Obes (Lond) 2007; 31 (10) 1617-1625
  CrossrefPubMedGoogle Scholar
• 104 Pasarica M, Sereda OR, Redman LM , et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009; 58 (3) 718-725
  PubMedGoogle Scholar
• 105 Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007; 455 (3) 479-492
  CrossrefPubMedGoogle Scholar
• 106 Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293 (4) E1118-E1128
  CrossrefPubMedGoogle Scholar
• 107 Yin J, Gao Z, He Q, Zhou D, Guo Z, Ye J. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 2009; 296 (2) E333-E342
  PubMedGoogle Scholar
• 108 Nakagawa Y, Kishida K, Kihara S, Yoshida R, Funahashi T, Shimomura I. Nocturnal falls of adiponectin levels in sleep apnea with abdominal obesity and impact of hypoxia-induced dysregulated adiponectin production in obese murine mesenteric adipose tissue. J Atheroscler Thromb 2011; 18 (3) 240-247
  CrossrefPubMedGoogle Scholar
• 109 Nakagawa Y, Kishida K, Kihara S , et al. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome. Am J Physiol Endocrinol Metab 2008; 294 (4) E778-E784
  CrossrefPubMedGoogle Scholar
• 110 Tanné F, Gagnadoux F, Chazouillères O , et al. Chronic liver injury during obstructive sleep apnea. Hepatology 2005; 41 (6) 1290-1296
  CrossrefPubMedGoogle Scholar
• 111 Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005; 50 (12) 2338-2343
  CrossrefPubMedGoogle Scholar
• 112 Tatsumi K, Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 2005; 33 (2) 100-104
  CrossrefPubMedGoogle Scholar
• 113 Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 2007; 41 (10) 918-921
  CrossrefPubMedGoogle Scholar
• 114 Jouët P, Sabaté JM, Maillard D , et al. Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obes Surg 2007; 17 (4) 478-485
  CrossrefPubMedGoogle Scholar
• 115 Mishra P, Nugent C, Afendy A , et al. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int 2008; 28 (8) 1080-1086
  CrossrefPubMedGoogle Scholar
• 116 Campos GM, Bambha K, Vittinghoff E , et al. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology 2008; 47 (6) 1916-1923
  CrossrefPubMedGoogle Scholar
• 117 Norman D, Bardwell WA, Arosemena F , et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 2008; 31 (1) 121-126
  PubMedGoogle Scholar
• 118 Polotsky VY, Patil SP, Savransky V , et al. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med 2009; 179 (3) 228-234
  CrossrefPubMedGoogle Scholar
• 119 Daltro C, Cotrim HP, Alves E , et al. Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?. Obes Surg 2010; 20 (11) 1536-1543
  CrossrefPubMedGoogle Scholar
• 120 Turkay C, Ozol D, Kasapoglu B , et al. Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. Respir Care 2012; 57 (2) 244-249
  PubMedGoogle Scholar
• 121 Aron-Wisnewsky J, Minville C, Tordjman J , et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 2012; 56 (1) 225-233
  CrossrefPubMedGoogle Scholar
• 122 Chin K, Nakamura T, Takahashi K , et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003; 114 (5) 370-376
  CrossrefPubMedGoogle Scholar
• 123 Kheirandish-Gozal L, Sans Capdevila O, Kheirandish E, Gozal D. Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest 2008; 133 (1) 92-99
  CrossrefPubMedGoogle Scholar
• 124 Shpirer I, Copel L, Broide E, Elizur A. Continuous positive airway pressure improves sleep apnea associated fatty liver. Lung 2010; 188 (4) 301-307
  CrossrefPubMedGoogle Scholar
• 125 Kohler M, Pepperell JC, Davies RJ, Stradling JR. Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. Respiration 2009; 78 (2) 141-146
  CrossrefPubMedGoogle Scholar
• 126 Savransky V, Nanayakkara A, Vivero A , et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 2007; 45 (4) 1007-1013
  CrossrefPubMedGoogle Scholar
• 127 Li J, Grigoryev DN, Ye SQ , et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 2005; 99 (5) 1643-1648
  CrossrefPubMedGoogle Scholar
• 128 Savransky V, Bevans S, Nanayakkara A , et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 2007; 293 (4) G871-G877
  CrossrefPubMedGoogle Scholar
• 129 Drager LF, Li J, Reinke C, Bevans-Fonti S, Jun JC, Polotsky VY. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 2011; 19 (11) 2167-2174
  CrossrefPubMedGoogle Scholar
• 130 Feng SZ, Tian JL, Zhang Q , et al. An experimental research on chronic intermittent hypoxia leading to liver injury. Sleep Breath 2011; 15 (3) 493-502
  CrossrefPubMedGoogle Scholar
• 131 Musso G, Gambino R, Cassader M. Need for a three-focused approach to nonalcoholic fatty liver disease. Hepatology 2011; 53 (5) 1773 , author reply 1774
  CrossrefPubMedGoogle Scholar
• 132 Harsch IA, Schahin SP, Brückner K , et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004; 71 (3) 252-259
  CrossrefPubMedGoogle Scholar
• 133 Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007; 29 (4) 720-727
  CrossrefPubMedGoogle Scholar
• 134 Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9 (3) 211-224
  CrossrefPubMedGoogle Scholar